C-Level
Jake Junkil Been
CEO
Jake invented 'The next generation neuro navigation system' with plentiful research background of numerical brain modeling and neuromodulation effect analysis in his Master’s degree at GIST (Gwangju Institute of Science and Technology). He started to plan to build company during his internship as a member of startup acceleration program at Kotra (Korea Trade and Investment Promotion Agency). He co-founded Neurophet to overcome brain disease with the belief that 'building start-up' is to solve the problem in the world. He is focused on overall business strategy, globalization, and regional sales as CEO of Neurophet.
DongHyeon Kim
CTO
DongHyeon is the co-founder, Chief Technology Officer of Neurophet. He received his Master’s degree at School of Information and Communications and Ph.D. at School of Electrical Engineering and Computer Science from GIST (Gwangju Institute of Science and Technology). He is the inventor of about 100 domestic and international patents related to treatment, diagnosis, and analysis, having published several articles in world-renowned journals. He received a commendation from the Minister of Health and Welfare of the Republic of Korea for his contribution to the development of AI-powered brain image analysis technology.
ChangIl Kim
CPO
ChangIl took several key engineering leadership positions such as CTO, head of R&D, product/project manager, software manager in GE Healthcare, Siemens Healthineers, and SAMSUNG GE Medical System leading lots of product development. As Chief Product Officer at Neurophet, he is devoted to developing advanced AI-powered brain image analysis solutions, including product planning, full life cycle development, and QA/RA process.
YoungJoon Moon
CBO
YoungJoon is responsible for global business. He is focused on the development of partnerships and marketing strategies for growing in the global marketplace. He received Ph.D. in life science from Chung-Ang University and completed Postdoc at New York University Langone Medical Center. He has published 10+ articles in SCI journals and has a variety of experience in global business and marketing at Celltrion Healthcare, Roche Diagnostics and NGeneBio.
HyunKook Lim
CMO
HyunKook holds both an M.D. and a Ph.D. from The Catholic University of Korea. He is working as a professor in the Department of Psychiatry at Yeouido St. Mary's Hospital, The Catholic University of Korea, and is the head of the Catholic Brain Health Care Center. He is a director of the board committee at the Korean NeuroPsychiatric Association, Korean Association for Geriatric Psychiatry, Korean Society of Biological Psychiatry, Korean Brain Stimulation Society, Society for Cognitive Intervention, and the National Medical Center. Additionally, he is the editor-in-chief of Psychiatry Investigation. As the CMO of Neurophet, he is focused on developing advanced products by leading clinical research related to dementia.
KwangMin Lee
CFO
KwangMin is in charge of management and finance. He holds the Korean Institute of Certified Public Accountant (KICPA) and worked at Deloitte Korea for several years in accounting audit and consulting. He has various experiences in the fields of accounting, tax, investment, and IPO at financial and healthcare companies such as Doosan Capital, Meritz Capital, Global Tax Free, and Corelinesoft.
Global Advisory Board
Philip Scheltens
Scientific Advisor
Professor Philip Scheltens, M.D., Ph.D., the world’s leading expert on dementia, developed Scheltens’ Scale, MRI criteria to score hippocampus atrophy for the diagnosis of Alzheimer's disease. He is a professor of neurology at Amsterdam University Medical Center, and director of the Alzheimer Center at the VU University Medical Center. Additionally, he is the chairman of the World Dementia Council and the Partner & Head of the Dementia Fund, EQT life Sciences.
Nagaendran Kandiah
Scientific Advisor
Professor Nagaendran Kandiah, M.D. is a leader of dementia research in Singapore-Southeast Asia with specialization in cognitive neurology and vascular neurology. He is an associate professor of Neuroscience and Mental Health at the LKC-Imperial Medical School, Senior Consultant Neurologist with National Neuroscience Institute (NNI), and the director of the NNI Dementia Programme. Also, he is a director of the Dementia Research Centre (Singapore) at LKC-NTU, associate professor of Neuroscience at Duke-NUS, Singapore, chairman of the Neurocognitive and Research Training Consortium of Southeast Asia (NRTC-SEA), and clinician scientist with National Medical Research Council.
Physicians
JinWook Choi
Medical Advisor
JinWook graduated from Kyungpook National University College of Medicine and trained at Samsung Medical Center. He is a professor at Ajou University Hospital in the radiology department. He is also a special director at Korean Society of Interventional Neuroradiology, a member of Korean Society of Radiology, Korean Stroke Society, Korean Society of Interventional Neuroradiology, Korean Society of Neuroradiology, and Korean Society of Magnetic Resonance in Medicine, and an examiner of Journal of the Korean Radiological Society, and Brain Tumor Research and Treatment. He supports the research and product development at Neurophet based on his medical knowledge as a medical adviser.
KiJeong Lee
Medical Director
KiJeong is a board-certified neurologist and received her Master's degree and Ph.D. at Yonsei University. She worked as a professor in the Department of Neurology at Yonsei University College of Medicine, and Seoul & Eunpyeong St. Mary’s Hospital, Catholic University of Korea. She served as a Board Member of Public Relations & Professional Education Committee of the Korean Stroke Society. Her primary focus of research is neuro-vascular diseases, and she is in charge of developing Neurophet’s neuro-vascular pipeline based on her clinical expertise and professional knowledge.
Jessica H.W. Kim
Medical Director
Jessica is a board-certified neurologist and licensed Doctor of Medicine in South Korea. Her expertise includes clinical fellowship and serving as a supervising neurologist at Asan Medical Center, and the establishment and management of Brain & Neurology Center as the Head Doctor and Director at Bang Hospital in Seoul. She received her MD from Yonsei University, and master's degree from Inje University. As the Medical Director, she supervises clinical research and medical aspects of regulatory approvals, collaborates with global KOLs, and serves as the key presenter at international medical conferences and meetings.
HyunJung Kim
Medical Director
HyunJung graduated from the College of Medicine at Pusan National University and received Ph.D. from The Catholic University of Korea. She worked at the Department of Family Medicine of CHA Bundang Medical Center and Seoul St. Mary’s Hospital, Catholic University of Korea. As a medical director at Neurophet, she analyzes and studies medical, technical, and commercial feasibility.
Director
Regina EY Kim
Director
Regina received a Ph.D. in Biomedical Engineering at The University of Iowa and worked as an associate research scientist & engineer conducting brain imaging analysis research at the department of Psychiatry. She served as a research professor, leading the brain image analysis research of Korean cohort KoGES at Korea University Ansan Hospital. Based on her research experiences related to MRI, she has published a number of papers and is in charge of research and technology development for brain image analysis and treatment.
DoHyun Kim
Director
DoHyun received Master's degree in Computational Biology from New Jersey Institute of Technology. He built his career in global medical device companies such as GE Healthcare, Samsung Medison, and Siemens Healthineers leading the project management, development, quality, production, and processes. He has been recognized for his expertise by winning Leadership Awards and Top Performance Awards. He is in charge of medical device quality management system and regulatory affairs, based on his expertise in development and production systems and software engineering.
MinHo Lee
Director
MinHo received his Ph.D. in Biomedical Engineering from AMIST (Asan Medical Institute of Convergence Science and Technology) and has conducted research using CT, X-ray, and MR images at Seoul National University Hospital and Asan Medical Center. More than 30 publications in SCI journals have been published by him related to medical images and artificial intelligence, and he is listed as the inventor of more than 30 patents. As an expert in developing technology using various medical images and artificial intelligence, he is leading not only the development of core technology including AI-based computer vision for Neurophet's flagship products such as Neurophet AQUA and Neurophet SCALE PET but also products related to neurovascular diseases.
HyungSeuk Yoon
Director
HyungSeuk is in charge of the patent application and research project for Neurophet’s products could be recognized for their feasibility and practicality in domestic and international markets. He worked at a major company in Korea and at Patent Office conducting patent analysis and national projects. He participated in a number of technology commercialization projects as an investigator and was selected as an excellent investigator.
ChangHoon Lee
Director
ChangHoon has been active in IT and SW industries as a developer for over 20 years. He experienced development and operation of services with a million MAU. He manages the development of Neurophet’s neurodegeneration related products based on his expertise in improving the development process and project management.
ByungSu Kim
Director
ByungSu developed UI/UX of ultrasound devices at Siemens Healthineers and he experienced developing, designing, and operating in the medical IT industry such as ezCaretech. He also developed and operated HIS at Seoul National University Bundang Hospital and hospitals overseas. Based on years of development experience, he is responsible for the development of neuro-vascular and neuro-modulation related products at Neurophet.
JinSoo Ko
Director
JinSoo worked at INFINITT Healthcare leading sales of PACS, Oncology, CIS, Ophthalmology solutions, and he won the Best Sales Award from the Korea Medical Devices Association. He has established the business department at DOUZONE BIZON and served as the head, resulting in various achievements such as winning a contract for P-HIS big data flatform business. He is focused on targeting Korean market and promoting growth as leading Neurophet’s domestic sales based on his field experience and expertise.
SuHwan Kim
Director
SuHwan is responsible for global and domestic marketing at Neurophet, ensuring that our AI solutions provide practical benefits to healthcare professionals and patients with neurological diseases. He holds an MBA from Korea University and a DVM (Doctor of Veterinary Medicine) from Kyungpook National University. Leveraging his medical expertise as a veterinarian, he has over 15 years of experience as a marketer with multinational pharmaceutical and healthcare companies such as Roche Korea, Abbott Korea, and GSK Korea. During his career, he has led the launch of various new products, including immuno-oncology drugs and HIV treatments.
JiYoung Lee
Director
JiYoung is in charge of human resources including recruitment, organizational culture, evaluation, policy and training. She has developed Neurophet Carrer, internal homepage and evaluation system to make recruitment and work environment efficient for new employees and she focuses on supporting organizational and individual growth in fast-growing organizations. Prior to joining Neurophet, she worked as a HR manager at RSUPPORT, GOM&COMPANY and TmaxSoft.
YoonKee Lee
Director
YoonKee is a communication expert specializing in IR, PR, governance, and stakeholder communication. Since joining Neurophet, he has specialized in IR/PR including developing internal and external communication strategies, manages risks, conducts market intelligence, and interacts with global investors. He graduated from Chung-Ang University with a degree in Business Administration and has gained capital market and communication experience at Yuanta Securities, Kolon, Hugel, and Hanssem.